Dementia and comorbidities in primary care: a scoping review

[21] Stolee P(2017)Comorbidity and polypharmacy in people with dementia: Insights from a large, population-based cross-sectional analysis of primary care data Age Ageing 46 33-189

[22] Moore A(2014)Comorbidity of dementia: a cross-sectional study of primary care older patients BMC Psychiatry. 13 84-738

[23] Frank C(2014)Comorbidity and dementia: A scoping review of the literature BMC Med. 12 192-372

[24] Chambers LW(2014)The importance of detecting and managing comorbidities in people with dementia? Age Ageing 43 741-473

[25] Wells CE(2021)The Impact of Disease Comorbidities in Alzheimer’s Disease Front Aging Neurosci 12 13-468

[26] Smith SJ(2002)Alzheimer Disease as a Vascular Disorder Nosological Evidence Stroke 33 1152-28

[27] Liss JL(2021)Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis Hypertension. 78 629-14

[28] Seleri Assunção S(2008)Hypertension, cognitive decline and dementia Arch Cardiovasc Dis 101 181-344

[29] Cummings J(2011)Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders Nat Rev Neurosci 12 723-551

[30] Atri A(2019)Toward a Sequential Strategy for Diagnosing Neurocognitive Disorders: A Consensus from the “Act On Dementia” European Joint Action J Alzheimers Dis 72 363-5908

[21] Stolee P(2017)Comorbidity and polypharmacy in people with dementia: Insights from a large, population-based cross-sectional analysis of primary care data Age Ageing 46 33-189

[22] Moore A(2014)Comorbidity of dementia: a cross-sectional study of primary care older patients BMC Psychiatry. 13 84-738

[23] Frank C(2014)Comorbidity and dementia: A scoping review of the literature BMC Med. 12 192-372

[24] Chambers LW(2014)The importance of detecting and managing comorbidities in people with dementia? Age Ageing 43 741-473

[25] Wells CE(2021)The Impact of Disease Comorbidities in Alzheimer’s Disease Front Aging Neurosci 12 13-468

[26] Smith SJ(2002)Alzheimer Disease as a Vascular Disorder Nosological Evidence Stroke 33 1152-28

[27] Liss JL(2021)Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis Hypertension. 78 629-14

[28] Seleri Assunção S(2008)Hypertension, cognitive decline and dementia Arch Cardiovasc Dis 101 181-344

[29] Cummings J(2011)Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders Nat Rev Neurosci 12 723-551

[30] Atri A(2019)Toward a Sequential Strategy for Diagnosing Neurocognitive Disorders: A Consensus from the “Act On Dementia” European Joint Action J Alzheimers Dis 72 363-5908